Safe Use of Long-Acting Opioids – The Legal Perspective

This program is developed through a providership between the University of North Texas Health Science Center and Antidote Education Company.

This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies.  Please see http://ce.er-la-opioidrems.com/IwgCEUI/rems/pdf/List_of_RPC_Companies.pdf for a listing of the member companies.  This activity is intended to be fully compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the US Food & Drug Administration.

Release date: February 27, 2015

Valid through: February 27, 2016

Specialty: Primary Care

Estimated Time to Complete: 60 minutes

Target Audience

This activity is intended to educate primary care and specialist providers who treat patients with chronic pain.

Program Overview

This session is the final in a four part series on managing chronic pain with extended release and long-acting opioids. 

Attorney Jennifer Bolen is joined by Dr. Bill McCarberg in a discussion of the legal aspects of treating patients with chronic pain. The duo will share insights in how to find the balance in managing risk and providing appropriate pain management. They will also discuss best practices in legal language documentation and informed consent.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  1. Know how to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.
  2. Recognize and discuss the regulatory, statutory and legal issues that complicate prescribing opioid analgesics.

Credit Available

  • Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ , 1.0 AOA Category 2B CME Credits, and/or 1.0 AAFP Prescribed Credit.
  • Nurse Practitioners — AANP Credit
  • Physician Assistants — AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit(s)™  from organizations accredited by ACCME or a recognized state medical society.

All other healthcare professionals completing this course will be issued a statement of participation.

Faculty

Jen Bolen, JD

Ms. Bolen has nearly 25 years cumulative experience and training as an attorney and regulatory compliance consultant in pain management and clinical drug testing laboratories, with 10+ years specifically as a nationally recognized expert in the pain and clinical drug testing industry and nearly 14 years as an Assistant US Attorney with the US Department of Justice.

Ms. Bolen regularly conducts practice audits and teaches providers how to perform self-audits with the intent of improving pain management documentation practices and patient relationships. She specializes in the creation and implementation of regulatory compliance programs and patient risk management protocols, including Physician Office Laboratories and Independent. She also specializes in laboratory coding, reimbursement, and fraud and abuse compliance issues. Ms. Bolen has served as a testifying expert witness on pain management law and compliance in federal and state court.

Bill H. McCarberg, MD

Bill McCarberg MD is Founder of the Chronic Pain Management Program for Kaiser Permanente (retired) in San Diego, California. He is currently working as a primary care physician with Neighborhood Healthcare and hospice provider in Escondido California.

Dr. McCarberg is president-elect of the American Academy of Pain Medicine. He is president of the Western Pain Society and Adjunct Assistant Clinical Professor at the University of California at San Diego School Medicine. Dr McCarberg is a member of the American Academy of Family Physicians, the American Pain Society, and the International Association for the Study of Pain. He is the recipient of several awards including the Shilling Compassionate Care Award, the Elizabeth Narcessian award for leader in the field of pain education from the American Pain Society and in 2008 was Ambassador of the Year for the National Pain Foundation. Member Appraisal of Physician Services at Kaiser Permanente rated Dr. McCarberg in the top 10% from 1998-2011.

Dr. McCarberg has given more than 250 presentations on pain management issues and is the author or co-author of 115 articles, book chapters and books. He is board certified by the American College of Pain Medicine, the American Board of Family Practice and additionally certified in Geriatrics. Dr McCarberg received his MD degree from Northwestern University Medical School in Chicago, Illinois. He completed a medical internship and a residency in family practice at Highland Hospital in Rochester, New York.

Accreditation Statement

The University of North Texas Health Science Center at Fort Worth is accredited by the American Osteopathic Association to award continuing medical education to physicians.

The University of North Texas Health Science Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of North Texas Health Science Center has requested that the AOA Council on Continuing Medical Education approve this program for 4 hours of AOA Category 2B CME credits.  Approval is currently pending.

The University of North Texas Health Science Center at Fort Worth designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This Enduring Material activity, Effective Strategies for Chronic Pain Management: Assessing Patients for Treatment has been reviewed and is acceptable for up to 4.0 Prescribed credits by the American Academy of Family Physicians. Term of approval begins 2/27/2015.  Term of approval is for one year from this date. Each webcast is approved for 1.0 Prescribed credit. Credit may be claimed for one year from the date of each webcast. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This program is approved for 4.0 contact hour(s) of continuing education (which includes 2.28 hours of pharmacology) by the American Association of Nurse Practitioners.  Program ID 1411483. This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards.

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit from organizations accredited by ACCME.

Disclosures of Conflicts of Interest

The University of North Texas Health Science Center (UNTHSC) and Antidote Education Company (Antidote) are committed to creating, developing, and operating high-quality, relevant, and practical continuing medical education activities that are in compliance with the ACCME's policies on commercial support and disclosure. Specifically, we are dedicated to ensuring that our activities are planned and implemented free of the control of commercial interests and to identifying and resolving conflicts of interest of all persons in a position to control the content of an educational activity before the educational activity occurs.

Individuals in a position to control the content of this CME activity reported the following relevant financial relationships with commercial interests:

Jennifer Bolen, JD
Consultant: Alere Toxicology, Quest Diagnostics, Sterling Healthcare Partners
Speaker's Bureau: Quest Diagnostics
Leadership Position: Board of Directors, American Society of Pain Educators

Bill H. McCarberg, MD
Leadership Position: President of the Western Pain Society; President Elect of the American Academy of Pain Medicine
Advisory Board: Iroko Pharmaceuticals, LLC; Pfizer; Zogenix Inc.; Collegium Pharmaceutical; Mallinckrodt Pharmaceuticals; Inspirion Pharmaceuticals; Salix Pharmaceuticals Inc.; Takeda Pharmaceuticals Company Limited; Depomed Inc.; Janssen Pharmaceuticals, Inc.

All UNTHSC and Antidote staff members and others involved in the planning, development and review of the content of this activity have no relevant conflicts of interest to disclose.

Instructions for Participation and Credit

This activity is comprised of 4 sessions.  Each session will take approximately 60 minutes to complete.  To receive credit, participants are required to complete the pre-test, view the online video and complete the post-test and evaluation form.  To receive credit, a minimum score of 70% must be achieved on the post-test.  A certificate will be immediately available.  There is no fee to participate in the activity or for the generation of a certificate.

Media

Internet streaming video

Hardware and Software Requirements

This site is best viewed with an HTML5 compatible browser, this list includes the versions of Mircrosoft Internet Explorer, Mozilla Firefox, Google Chrome, and Apple's Safari. You can visit the independent (3rd party) site www.whatismybrowser.com to determine if you have the latest version of your browser. Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. That software may be: Adobe Flash, Apple Quicktime, Adobe Acrobat, Microsoft Powerpoint, Windows Media Player, and Real Networks Real One Player.

Disclosure of Unlabeled Use

This activity does not include intentional, prescribed unlabeled use of pharmaceuticals.  There is discussion of the consequences of drug misuse.

Disclaimer

The University of North Texas Health Science Center presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

Copyright

This educational program and its content are copyright 2014-2015 by Antidote Education Company and the University of North Texas Health Science Center.